MVision AI
News and Articles

Keep up to date with our latest articles

Hot Topics 🔥

Press Room

19.1.2022

MVision’s Guideline-Based AI Segmentation is Available in the EduCase Platform

Helsinki - 19th of January, 2022 - MVision AI, the leading provider of the guideline-based solution, collaborates with EduCase, the global leader in web-based education designed to support contouring skill instructions for radiation oncologists. EduCase is a computer-based training tool developed by RadOnc eLearning Center, LLC., to assist the development…

News, Press Releases

7.1.2022

What guidelines do clinicians follow for breast contouring?

According to the NHS, breast cancer is the most common type of cancer in the UK. Roughly 1 in 8 women are diagnosed with breast cancer during their lifetime. However, there is a good chance of recovery if the cancer is detected early. (NHS) The World Health Organization estimates that…

News

29.12.2021

2021 MVision AI Re-cap: The Year of GCAIS™

2021 is an innovative and  foundational year for MVision AI. We are proud of what we have accomplished so far and super excited about what is in store for us in the future. One feeling that stands out as we look back at 2021 is gratitude. We thank everyone who…

News

9.12.2021

Medron Medical Systems Inc. is Introducing MVision’s Groundbreaking Auto-Segmentation Solution to Canada

Helsinki – December 9, 2021 – MVision AI, the leading software service provider of guideline-based AI segmentation, GBAIS™, for radiotherapy treatment planning, declares a new distribution partnership with Medron Medical Systems, Canada’s choice health equipment provider (subject to approval from Health Canada). (more…)

News, Press Releases

3.12.2021

Important Methods for Radiotherapy Treatment

 60-70% of cancer patients receive some type of radiation therapy. For some cancers, radiation therapy alone is an effective treatment. The purpose of radiotherapy is to destroy cancer cells and slow tumor growth while limiting the harm to nearby healthy tissue. When it is not possible to destroy all of…

News

24.11.2021

SBRT as an Effective Modality for Lung Cancer Treatment

Stereotactic body radiotherapy (SBRT), or stereotactic ablative body radiotherapy (SABR), is an innovative radiation therapy technique. The technique uses special equipment to precisely deliver a dose of radiation to a tumor. SBRT aims to employ the highest possible dose of radiation to kill cancer while minimizing damage to surrounding tissues…

News

17.11.2021

Examining the Capacity of Radiotherapy to Treat Lung Cancer

Radiotherapy is an important modality used for the treatment of lung cancer. Nearly 80% of all patients with lung cancer have an evidence-based indication for radiotherapy. (Vinod, Shalini K., and Eric Hau.) If evidence-based radiotherapy recommendations were followed by the entire population of lung cancer patients, it is estimated that…

News

5.11.2021

YourRad AB is Providing MVision’s AI-Powered Segmentation Service to Nordic Cancer Hospitals

Helsinki - 5th of November, 2021 - MVision AI, the pioneer of SaaS radiotherapy treatment planning optimization, announces their distribution partnership YourRad AB, the prime supplier of radiation treatment products for Nordic Clinics. The commitment authorizes YourRad AB with the entitlement to distribute products and services of MVision AI in…

Press Releases

22.10.2021

The Current State of Cancer Care and Radiotherapy in the US

The rate of new cases of cancer yearly is 442.4 per 100,000 amongst men and women per year (based on 2013–2017 cases). The most common cancers cases in 2020 were breast cancer, lung and bronchus cancer, prostate cancer, and colon and rectum cancer. Of the patients treated with cancer in…

News

MVision-Local-Server-Omen

8.10.2021

MVision’s On-Premise Solutions

Since the invention of the world's first web server in 1989, servers have shaped our society and technology today. In 2020 alone, the global server market revenues reached over 91 billion USD, with 12.15 million server shipments worldwide. The fact that you can read this from your laptop, PC, MAC,…

News

29.9.2021

AQUILAB Ushers In MVision’s Innovative and Guideline-Compliant AI Segmentation Solution to France

Helsinki - 29th of September 2021 - MVision AI, the leading service provider of guideline compliant radiotherapy software, announces a new distribution partnership with AQUILAB, the chief provider of revolutionary oncology software solutions throughout France.  (more…)

News, Press Releases

21.9.2021

New Horizons for Patients with Endometrial Cancer

September is Uterine Cancer Awareness Month. Raising awareness is very close to the MVisionaries since uterine cancer is the fourth most common cancer for women. It is estimated that 66,570 people in the United States alone will be diagnosed with uterine cancer this year. 90% of uterine cancers are endometrioid…

News

Testimonials

Hear what people say about us.

Customer Portfolio